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Abstract
In the present study, we analyzed the functional profile of CD8+ T-cell responses directed against autologous transmitted/
founder HIV-1 isolates during acute and early infection, and examined whether multifunctionality is required for selection of
virus escape mutations. Seven anti-retroviral therapy-naı¨ve subjects were studied in detail between 1 and 87 weeks
following onset of symptoms of acute HIV-1 infection. Synthetic peptides representing the autologous transmitted/founder
HIV-1 sequences were used in multiparameter flow cytometry assays to determine the functionality of HIV-1-specific CD8+ T
memory cells. In all seven patients, the earliest T cell responses were predominantly oligofunctional, although the relative
contribution of multifunctional cell responses increased significantly with time from infection. Interestingly, only the
magnitude of the total and not of the poly-functional T-cell responses was significantly associated with the selection of
escape mutants. However, the high contribution of MIP-1b-producing CD8+ T-cells to the total response suggests that
mechanisms not limited to cytotoxicity could be exerting immune pressure during acute infection. Lastly, we show that
epitope entropy, reflecting the capacity of the epitope to tolerate mutational change and defined as the diversity of epitope
sequences at the population level, was also correlated with rate of emergence of escape mutants.
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Introduction
The development of vaccines capable of controlling infections
by intracellular pathogens, including HIV-1, poses major
challenges, since correlates of protection remain elusive [1,2].
The initial observation that the appearance of HIV-specific CD8+
T cell responses is temporally associated with the resolution of
peak viremia suggested that they may represent a critical
component of initial protective immunity in humans [3,4,5].
Modeling based on the dynamics of the immune response and
epitope escape data from very early in infection provides further
support for the key role of CD8+ T cells responses in containing
the virus during acute and early infection [6].
CD8+ T cell responses are undoubtedly able to place substantial
pressure upon the virus, as indicated by the rapid appearance of
escape mutations following HIV infection [7,8,9,10]. In some
cases, the appearance of these escape mutants is associated with
the loss of virologic control, resulting in disease progression in
HIV-1 [11,12] and SIV infection [13,14,15]. However, CD8+
escape mutations do not always precede disease progression, and a
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number have been shown to result in a fitness cost that can lessen
the replicative capacity of HIV [16,17,18,19] and SIV [16,20,21].
Previous observations in chronic infection have shown that CD8+
T cell multifunctionality is associated, with slow HIV disease
progression [22,23]. CD8+ T cell responses exert significant
immune pressure on HIV-1 in acute infection that results in rapid
immune escape implying that they are important in early control of
the virus [6,24]. In the present report, we characterized the
functional profile of CD8+ T cell responses directed against the
transmitted/founder HIV-1 isolates arising during acute and early
infection in order to determine the relationship between the
functionality of epitope-specific CD8+ T cells and the selection of
transmitted/founder virus escape mutants.
Results
Clinical parameters and course of viremia
The seven study participants were males between 23 and 56
years old at the time of diagnosis and all were infected as
consequence of homosexual intercourse (MSM) (Table 1). The
participants were enrolled within 3 weeks following onset of
symptoms (FOSx) of acute HIV-1 infection. At the time of
screening, the three patients enrolled in CHAVI 001 were
classified as Fiebig stage 2, whereas the four patients enrolled at
the Mortimer Market Center were stage 3. None elected to receive
anti-retroviral therapy following diagnosis of acute HIV-1
infection and for the duration of the study. The analysis of the
CD4 slopes (Figure 1A) and plasma virus load (pVL) (Figure 1B)
were conducted according to previous publications [25] and
revealed: 1) a sustained loss of CD4 cells in 4 patients (MM33,
MM39, MM42, MM43), and 2) pVL set point at 40 weeks was
above 2,000 copies/ml in all but patient CH058. In our study, a
controller was classified as having a pVL of less than 2,000 RNA
copies/ml at three consecutive time points during the first 12-
month period (CH058, Figure 1A). Accordingly we identified one
controller (CH058) and six non-controllers that each had greater
than 2,000 copies/ml at multiple time points (Figure 1A).
Functional profile of Gag-specific CD8+ memory T cell
responses
We initially analyzed the magnitude and kinetics of the total
autologous Gag-specific CD8+ memory T cell response in each
subject between 1 and 87 weeks (WFOSx) of acute HIV-1
Author Summary
An important role for the polyfunctional T-cell fraction of
anti-HIV CD8 responses during chronic HIV infection has
previously been suggested. This study characterized the
role of polyfunctional T-cells directed against the trans-
mitted/founder virus in the selection of viral escape
mutants during acute HIV-1 infection within a unique
cohort of individuals recruited within 3 weeks from the
onset of symptoms at the time when the virus load was
still declining. For the first time, the sequences of the
transmitted/founder virus isolated from each patient were
used. Interestingly, polyfunctionality was not found to be a
pre-requisite for selection of escape mutations. A novel
significant correlation is found between the order of
appearance of escape mutations in different epitope
sequences and both the magnitude of the CD8+ T-cell
responses and the degree of entropy of the individual
epitopes. A high proportion of the T-cells participating in
the total response produced MIP-1b, suggesting that
mechanisms not limited to the killing of infected cells
might play a relevant role in early infection. This highlights
the importance of measuring the quality of the CD8+
lymphocyte response and the sequence of the transmitted
virus isolates to better understand the mechanisms of
control of HIV replication during acute infection.
Table 1. Patient demographic, CD4 slope, and plasma virus load set point, and class I HLA.
Patient ID/Class I HLA alleles Gender Agea Transmission Fiebigb CD4 slope pVL at Setpointwk40
c
CH040 M 56 MSM 2 0.772762.095 7580
A*3101,*0201; B*4402,*4001;
C*0302; C*0501
CH058 M 23 MSM 2 2.73362.336 199
A*0101,*2301; B*1402,*5701;
Cw*0701 C*0802
CH077 M 23 MSM 2 0.268761.994 5422
A*0205; B*5301,*5701; C*0401: C*1801
MM33 M 36 MSM 3 22.40660.9509 57200
A*0201,*6801; B*0702,*4402;
Cw*0501; Cw*0702
MM39 M 37 MSM 3 20.498760.5685 56350
A*0201,*0301; B*1501,*3501; Cw*09,*0401
MM42 M 45 MSM 3 23.59361.984 151150
A*3201,*0201; B*0702,*3906; Cw*1502,*0702
MM43 M 41 MSM 3 23.25460.8993 190050
A*0201; B*5501,*4001; Cw*10, *09
a. Age at time of infection;
b. Fiebig stage at screening;
c. The data represent the average value of the plasma virus load (pVL) between week 36 and 56 in copies/ml.
doi:10.1371/journal.ppat.1001273.t001
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infection along with associated multifunctional attributes of
responding cells. Peripheral blood mononuclear cells (PBMC)
cryopreserved at sequential time points FOSx were stimulated
with a pool of overlapping peptides corresponding to the entire
Gag sequence of the autologous transmitted/founder virus. The
responses were evaluated by multiparameter flow cytometry,
measuring the ability of CD8+ memory T cell subsets to
degranulate (CD107a expression) and/or produce IFN-c, IL-2,
MIP-1b, and TNF-a (Figure S1). In 5 patients, Gag-specific
CD8+ T cell responses were detected within 2–3 WFOSx and in
all patients by 8 weeks WFOSx. The frequency of responding
memory CD8+ T cells is reported within each pie chart (average6
standard deviation) in Figure 2. Analysis of the absolute
magnitude of the responses did not reveal a reduction in the
frequency of responses over time in each patient. The proportion
of each responding population found to exhibit 1, 2, 3, 4 and 5
functions at each time point is presented in the pie charts
(Figure 2A), while the relative frequencies of cells exhibiting each
number of functions are reported in the graphs (Figure 2B). The
analysis of the polyfunctional profiles among the seven patients
indicated that Gag-specific CD8+ subsets mediating $3 functions
contributed less than 20% of the total response in each subject at
the two earliest time points (2–3 and 4–8 WFOSx) (Figure 2A
and 2B). However there was some increase in the functionality of
Gag-specific responses with time from infection. The comparison
of contributions of each functional family to the overall response at
different time points revealed that the families with 3 and 4
functions were significantly higher after 78 WFOSx compared to
Figure 1. CD4 cell counts and virus load. A. The CD4 counts are reported in cell/mm3 at each time point following the onset of symptoms. B.
The virus load in each subject is reported on a logarithmic scale as RNA copies/ml at each time point following the onset of the symptoms. The black
dotted line represents the limits of 2,000 copies/ml used to identify controllers based on the CHAVI definitions of less than 2,000 copies/ml at 3
consecutive time points in 12 months.
doi:10.1371/journal.ppat.1001273.g001
Determinants of Escape in Acute HIV-1 Infection
PLoS Pathogens | www.plospathogens.org 3 February 2011 | Volume 7 | Issue 2 | e1001273
at earlier time points (p = 0.021 and 0.032, respectively, according
to the LME model analysis), but remained below 20% of the total
response in all but one instance. We also observed an absence
(,0.005%) of the highly multifunctional IFN-c+IL-2+MIP-
1b+TNF-a+CD107+ subset at all time points tested. This was
attributable to an absence of IL-2-producing CD8+ T cells (data
not shown). The profile of the Gag-specific response in the
controller CH058 was no different from those detected in the
other six non-controller patients at any time points, and therefore
it is not presented as segregated data.
Polyclonal stimulation induces highly multifunctional
CD8+ responses
We next determined whether this initial absence of highly
multifunctional responses was due to a general functional
impairment of the memory CD8+ T cell population. We
stimulated PBMC from each HIV-infected and non-infected
control subject with the superantigen Staphylococcus aureus entero-
toxin B (SEB) in order to detect the presence of the different
functional subsets in response to a polyclonal stimulus. The
frequency of cells in the total CD8+ memory T cell population
responding to SEB in the non-infected individuals was not
significantly different (p.0.05) to that observed in the HIV-
infected subjects within the first 8 WFOSx as reported in Figure 3.
We detected every functional family including IFN-c+IL-2+MIP-
1b+TNF-a+CD107+ cells with a frequency greater than 0.05% in
both HIV seronegative and seropositive individuals. This suggests
that the limited contribution of cells with $3 functions may be
confined to antigen-specific populations.
Functional profiles of responses to mutating and non-
mutating epitopes are similar
As the second aim of our study, we characterized the functional
profile of CD8 responses directed against 23 individual epitopes
previously mapped in the 7 subjects within HIV gene products not
limited to Gag, as detailed in Table 2. The epitopic sequences are
reported as those of the 18-mer peptides used to test the responses.
18-mer peptides were chosen for analysis of responses because we
did not want to preclude characterization of responses that were
not directed against previously described optimal epitopes (which
was the case for 5 of the 23 epitopes reported in Table 2). In a
side-by-side comparison, stimulation with representative 18-mers
Figure 2. Functionality of Gag-specific responses. The total frequency of Gag-specific CD8+ memory T cells within the memory CD8+ T cell
pool is reported within each pie as mean 6 standard deviation. A) The pie charts represent the relative contributions of each functional family to the
total response at each time point for the seven HIV-1 infected subjects. The color code for each number of functions is reported below the x-axis of
the graph. The number of subjects studied at each time point is reported under each pie chart. B) In the graph each point represents one subject,
and they are color coded according to the legend in the figure to represent the different weeks following onset of symptoms (WFOSx). Each grey box
represents the inter-quartile distribution of the responses. The graphs represent the relative contribution to the total response made by each
functional family at each time point. The trend line and p values for the statistically significant increase in subsets with 3 and 4 functions are also
reported in the graph.
doi:10.1371/journal.ppat.1001273.g002
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compared to optimal length peptides showed no differences in the
functionality of the stimulated CD8+ T cells (data not presented),
and we did not observe CD4+ T cell responses recognizing
overlapping epitopes within the 18-mer peptides. The epitopes
studied all elicited early T cell responses, previously mapped by
ELISpot assay [6,26], and could be detected by ICS within the
first 6 WFOSx, except for epitopes c, e, and f in CH040, responses
to which were first detected at week 12 (c and e) and 24 (f). As
shown in Figure 4, we performed longitudinal sequence analysis
of the viral quasispecies in each individual to reveal mutations
within the epitope and/or 9 aa of the C- and N-flanking regions
(all epitope variants are included in the Figure S1) that were
either hypothesized or subsequently demonstrated to confer escape
from the epitope-specific T cell response [6,26]. Based on this
definition, we detected the presence of escape mutations in twelve
epitopes within 0–55 WFOSx and in seven additional epitopes
between weeks 56 and 87. According to the time of detection of
escape, the two groups are referred to as early (e-ME) or late (l-
ME) mutating epitopes (ME) in Table 2 and Figure 4,
respectively. There was no evidence for mutation or escape in
Figure 3. Functionality of SEB responses. The frequency of SEB-responsive CD8+ T cells (irrespective of their functional profile) within the total
memory CD8+ T cell pool is shown above each pie. The pie charts represent the relative contribution of each functional family to the total response
for the non-HIV-infected (SN; left pie charts) and infected donors (SP; right pie charts). The responses in the latter group represent those detected
within the first 8 weeks post-onset of symptoms. The color code for each functional family is reported below the x-axis of the graph. Each dot
represents one individual in the graph and color codes for the two groups are reported at the bottom of the figure (brown SN; blue SP). Each grey
box represents the inter-quartile distribution of the responses. The graph represents the frequency of each functional family within the total SEB-
responsive population for the subjects in each group.
doi:10.1371/journal.ppat.1001273.g003
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the other four epitopes within the time frame of this study; these
are referred to as non-mutating epitopes (nME). The dynamics of
appearance of escape and the loss of transmitted virus sequences
are illustrated as the shaded gray bars above each epitope.
According to the appearance of mutations, the epitopes are ranked
within each patient both in Table 2 and Figure 4 (lower case
letter in the ‘‘Epitope’’ column and row, respectively). The time of
the earliest observed and the highest recorded frequency (HRF) of
CD8 T cell responses for each epitope are also reported in
Figure 4. Importantly, T cell responses were detected prior to the
emergence of the epitope variants in 16 out of 17 escaping
epitopes. The HRF occurred prior to the loss of transmitted virus
in all epitopes but two, epitope ‘‘c’’ (Env 830–847) and ‘‘b’’ (Gag
236–235) in patients CH040 and CH077, respectively.
We further analyzed the responses according to the profile of
the functional families at the earliest detectable time point, and at
Figure 4. Timing of escape of each epitope relative to the first CD8+ T-cell responses. In studies of this kind, the timing of escape
mutations and rate of loss of the transmitted form of epitope are based on limited temporal sampling of viral RNA from the plasma. Therefore, the
time that immune escape was initiated can only be resolved to a period between the sample where only the transmitted epitope was present, and
the sample where the first evidence of the accumulation of escape mutations appears. Similarly, the loss of the transmitted form can be prolonged or
rapid, and in some cases was still ongoing at the last time point sampled. To illustrate and rank the order of escape while conveying the uncertainty
of the rate and timing due to inevitable limitations in sampling, we used gradations of a grey bar, fading in during the period between the two
samples when selection first is initiated, and ending at the sample where the transmitted form was no longer evident; the transmitted form
diminishes through this period, and escape forms accumulate, indicated by the darkening gray. If the transmitted form was still present in the last
available sample, we ended with a question mark to indicate selection was still ongoing. Four epitopes that elicited ICS responses that showed no
evidence for escape during the course of the study are highlighted in red. Open blue circles indicate the timing of the sample where the first CD8+ T
cell response was observed against the epitope, the light blue dots indicate time with the highest response to the epitope (HRS). The rank order of
escape (reported for each epitope listed in Table 2 within each patient by the lower case letter as ’’epitope’’) provides the values used for the
correlation tests comparing order of escape to epitope entropy and the fraction of CD8+ T cell subtypes.
doi:10.1371/journal.ppat.1001273.g004
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the time of HRF of the response. At the level of group analysis
within the first 24 WFOSx (Figure 5A), we observed greater
representation of the monofunctional subset in the responses
against the early and late mutating epitopes than those against the
non-mutating epitopes, whereas cells mediating 2 and 3 functions
were relatively more abundant in the non-mutating-epitope-
specific responses (.30%). These profiles changed slightly at the
time of HRF, which for 12 out 23 (52%) epitope-specific responses
was after 24 WFOSx. There was some overall increase in
functionality with the 2- and 3-functional subsets contributing
more to the responses for each group of epitopes, in line with the
data reported in Figure 2. Interestingly, the 4-functional subset
contributed more to responses to the non-mutating epitopes
(Figure 5B). We confirmed that the IFN-c+IL-2+MIP-1b+TNF-
a+CD107+ subset made a negligible contribution to the overall
response, with frequencies ,0.005% at all time points analyzed.
Epitope sequence entropy and total frequency of
functional CD8+ T cell responses are both associated with
the temporal appearance of escape mutants
Given no clear correlation between functionality and virus
escape, we hypothesized that rapid selection for CD8+ T cell
escape mutants might be a function of both the intrinsic ability of
the targeted epitope to tolerate change as well as the patient’s
immune pressure exerted by the epitope-specific CD8+ T cell
responses whether detected at the earliest or HRF time point. To
provide a relative measure of how readily the epitopes included in
this study tolerate change, we calculated the Shannon entropy of
each epitope based the full collection of B clade sequences in the
Los Alamos database. Highly conserved epitopes will have a low
entropy score, and variable epitopes that frequently are altered
and clearly tolerate many patterns of substitution at the population
level will have a high entropy (see Methods for details). We
indicate in Figure 4 when the first evidence for selection and the
last traces of the transmitted epitope were observed. In some cases
the population completely shifted from transmitted to escape
variants between 2 sampling time points. In other cases selection
manifested gradually, with escape mutations accruing slowly over
many months. In 4 cases, escape mutations in recognized epitopes
did not arise within the time frame of the study. We ranked the
order of escape for each epitope within each subject based on the
temporal appearance of mutations (Table 2 and Figure 4). By
using a Spearman’s r statistic as described in the methods to assess
correlations, we observed a significant association of the temporal
appearance of mutation with both the entropy of the epitope
(p = 0.007) and the total frequency of CD8+ T cell responses
Figure 5. Analysis of functional profile of responses to mutating and non-mutating epitopes. The relative contributions of each
functional family to the total CD8 T cell response are reported within each pie chart for epitopes that mutated within 55 (early-mutating: e-ME) and
56–87 WFOSx (late-mutating: l-ME) and for those that did not mutate (non-mutating: nME) epitopes. A) Profile of responses within 12 weeks FOSx. B)
Profile of responses at the time of detection of the highest response by ICS (peak). The color code for each functional family is reported below the x-
axis of the graph. In the graph each dot represents a single epitope. The color code for each group of epitopes is reported at the bottom of the
figure. The grey bar represents the inter-quartile distribution of relative frequency of each functional family for the e-ME-, l-ME, and nME responses.
doi:10.1371/journal.ppat.1001273.g005
Determinants of Escape in Acute HIV-1 Infection
PLoS Pathogens | www.plospathogens.org 8 February 2011 | Volume 7 | Issue 2 | e1001273
detectable at the earliest time point (p = 0.03) as reported in
Table 2.
Relative contribution of T cells producing MIP-1b to the
overall response is significantly greater for early-ME-
specific responses
As analysis of the functional families at the individual patient
level revealed an association of total responses and ability to select
for escape mutations, we investigated whether this association may
reside at the level of any single or combination of the five
functional parameters. We noticed that CD8+IL2+ T cells did not
contribute to any of the three groups of epitope-specific responses
and that the majority of CD8+TNF-a+ were also CD8+IFN-c+ T
cells, therefore, we analyzed the remaining response subsets
without regard to production of IL2 and TNF-a. We observed that
the earliest recorded frequency of the CD8+ T cells producing
MIP-1b+ alone and in any combination with any other parameter
was also significantly associated with the appearance of escape
responses within subjects (Table 2, p = 0.006). A complication in
interpreting the role of MIP-1b+CD8+ T cells on immune pressure
is that their frequency is highly correlated with the total ICS
memory fraction at the earliest time point, making it difficult to
resolve which parameter, the total response or MIP-1b+, is driving
the pace of immune escape. The median relative contribution of
total CD8+MIP-1b+ T cells was .80% to all ME-specific
responses at early time points, as shown in Figure 6A, and
declined with time for the l-ME and nME groups as shown in
Figure 6C. We further analyzed whether degranulation or IFN-c
production were also associated with the significant predominant
contribution of CD8+MIP-1b+ cells to responses to e-ME. As
shown in Figure 6B and 6D, among the possible CD8+MIP-1b+
subsets with more than one function we could identify that both
CD8+MIP-1b+CD107+ and CD8+MIP-1b+CD107+IFN-c+ sub-
sets contributed to the e-ME-specific responses but also made a
similar contribution to the l-ME and nME responses. Moreover,
segregate analysis of both total CD8+IFN-c+ (p = 0.99) and total
CD8+IFN-c+ MIP-1b+ (p = 0.27) subsets did not reveal any
significant association with the appearance of escape mutants.
Thus, we observed that the MIP-1b-producing CD8+T cells
represent the dominant proportion of cells detectable in the early
stage of infection prior to virus escape, and that this was strongly
associated with immune pressure resulting in selection of the early
escape mutants.
Discussion
The results of both the STEP and RV144 clinical trials suggest
that CD8+ T cell responses alone might neither prevent HIV-1
infection nor lower virus set-point after infection [27,28].
However, given the relatively weak and narrow T-lymphocyte
responses were induced by the vaccine protocol used the in the
STEP trial [29], and encouraging non-human primate vaccine
studies [30,31,32] it is still important to continue this approach.
Thus, features of HIV-specific CD8+ T cells that determine their
in vivo efficacy need to be defined. It has been widely documented
that CD8 T cell responses are elicited early following HIV-1
infection and that they are associated with control of viremia as
well as with selecting for escape mutants that may impact virus
fitness [33]. As their most important impact may take place
during acute infection, we have focused our study on character-
ization of the functionality of HIV-specific CD8 T cell responses
at this time, concentrating on epitope-specific responses which
did or did not drive selection for escape mutations of the
transmitted virus.
We evaluated CD8+ T cell responses using 18-mer peptides
corresponding to the autologous transmitted/founder viral
sequence of seven individuals recruited within 45 days from the
onset of acute HIV-1 infection [6,26]. We first studied the total
response to the gag gene product, because of its importance in
vaccine design, and then extended the study to epitopes that we
had previously characterized for escape mutants because of their
potential impact on virus set point [6,26]. We observed that: 1)
more than 80% of the epitope specific T cells in acute infection
were oligofunctional; 2) MIP-1b-producing T cells were associated
with epitopes that escaped; 3) transmitted/founder virus escape
mutants in acute infection occur in epitopes that have high entropy
at the population level.
Previously in chronically infected patients, multifunctionality of
HIV-specific CD8+ T cell responses in the peripheral blood has
been shown to be associated with long-term non-progression
[22,23], and it has been related to the CD4 count and inversely
related to the virus load at the rectal mucosal level [34]. In our
study, we characterized the earliest functional responses and
observed that the early CD8 T cell response was predominantly
mono- or bi-functional. The contribution of T cells with 3-5
functions was small but increased with time from infection and we
cannot exclude that they become a major subset as the infection
progresses, particularly in those who control the infection well, as
previously described. Although we cannot exclude the possibility
that the presence of early poly-functional CD8+T cell responses
may predict control of viremia, the observation that the only
controller in our cohort displayed a profile of functional responses
similar to those who did not control virus replication would suggest
otherwise. Our observations are largely in agreement with those
made by Streeck and collaborators, who reported an increase in
poly-functionality with the appearance of escape mutants and a
subsequent decrease in functionality over time [35]. In fact, we
likewise observed an increase in functionality of epitope-specific
CD8+ T cell responses from the early to the HRF time point,
although, we showed that only the total CD8+ T cell responses
were significantly associated with the appearance of escape
mutations. This could be related to the fact that, in our study,
responses were detected in most cases before full escape occurred
when virus load had not yet reached the virus set-point. The
initially low level of multifunctionality might be related to high
levels of virus replication that would in turn favor upregulation of
inhibitory receptors such as PD1. Such upregulation would have a
negative impact on the functionality of the CD8+ T cells – an
impact that is rescued in chronically-infected individuals upon
control of VL following initiation of therapy [36,37]. By
comparing our data to those obtained from individuals immunized
with MVA to protect against smallpox virus infection [38], we also
hypothesize that HIV-specific CD8 responses may be substantially
delayed in acquiring multifunctionality because of impairments in
CD4+ T cell populations, which are otherwise preserved and
functional in MVA vaccine recipients. It is, therefore, possible that
maturation of HIV-1 specific multifunctional CD8+ T cell
responses might be affected by both the impact of high levels of
virus replication and the early loss of CD4+ T helper function.
In the present study we also sought to characterize whether the
functionality of the CD8+ T cell responses generated during acute/
early HIV-1 infection may be related to the immune pressure
exerted on the transmitted virus. For the 19 ME epitope-specific
CD8+ T cell responses studied, the total magnitude of functional
CD8+ T cell response at early time points was significantly
associated with the early appearance of escape mutations, when
responses were mainly oligofunctional. Multifunctional T cells
were a minor component of the response. The observation of the
Determinants of Escape in Acute HIV-1 Infection
PLoS Pathogens | www.plospathogens.org 9 February 2011 | Volume 7 | Issue 2 | e1001273
overall impact of the magnitude of functional T cell responses on
the appearance of escape mutations is in agreement with previous
results obtained by the analysis of IFN-c+CD8+ T cell responses,
although, in this cohort of patients the IFN-c+ responses alone did
not show significant association with the appearance of escape
mutants [26,39]. Other characteristics of the T cell responses to e-
ME may also have influenced the rate at which they were escaped.
For example, e-ME may generally elicit clonal CD8+ T cell
populations with higher avidity [40,41,42] and/or a better
selection of a T cell receptor (TcR) repertoire, as suggested by
Figure 6. Analysis of individual functions and polyfunctional subsets. The analysis of the responses at the earliest (panelsA andB) and highest
recorded (panels C and D) time points are shown. The pie charts represent the relative contribution to the total response of cells exhibiting each
functional parameter or combination of functional parameters. The color code for each parameter (pie slice) is reported below the x-axis of the graph. In
the graph, each triangle represents the early (e-ME), late (l-ME), and non-mutating (nME) epitope-specific CD8+ T cell response detected at each time
point by ICS. The color code for each group of epitopes is reported at the bottom of the figure. The grey bars represent the inter-quartile distribution of
the relative frequency of each functional parameter. The dots under the x-axis represent the positive responses for each parameter. (A andC) Total MIP-
1b+ responses are compared to the total responses detected as any combination of the other parameters excluding MIP-1b. (B and D) Analysis of the
single or combined contribution of degranulation (CD107), IFN-c and MIP-1b production is represented by the dots under the x-axis.
doi:10.1371/journal.ppat.1001273.g006
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both human and NHP studies [42,43]. These questions are being
addressed separately.
Further analysis of the proportion of epitope-specific T cells
producing individual cytokines revealed for the first time that MIP-
1b+-producing CD8+ T cells constituted greater than 80% of the cells
participating in the early responses and, therefore, were associated
with the appearance of escape mutants. The contribution of MIP-
1b+-producing CD8+ T cells to the overall response declined with
time for the l-ME and nME responses, suggesting that persistent
antigenic stimulation might also be an important factor in selecting
for clones whose functional profile is dominated more by IFN-c+
production as part of the maturation process [44]. Among the
CD8+MIP-1b+ responding cells, we observed that CD8+MIP-
1b+CD107+ and CD8+MIP-1b+CD107+IFN-c+ T cells were the
two multifunctional subsets most highly contributing to the early
responses. We have recently demonstrated that CD8+ T cell
mediated antiviral function in virus controllers and vaccinees is
associated with Clade B Env and Gag-specific MIP-1b and CD107a
expression as monofunctional and dual-functional populations,
suggesting the importance of both cytolytic and non-cytolytic
mechanisms in control of HIV replication [45]. CD8+ T cells can
suppress HIV-1 replication noncytolytically through the secretion of a
number of soluble factors, including the B-chemokines, MIP1a,
MIP1b and RANTES, which can potently inhibit CCR5 tropic virus
infection [46]. We have found that the secretion of MIP-1a, MIP-1b,
IP-10, MIG, IL-1, and interferon gamma correlated most strongly
with soluble noncytolytic suppression [47]. Using the ability of histone
hyperacetylation to alter the expression of immune-related genes, we
identified that MIP-1a and IP-10 were also among the genes that
were down-regulated by histone hyperacetylation; again supporting
the idea that they contributed to soluble CD8+ T cell mediated
suppression [47,48]. Taken together, these observations suggest that
T cells involved in selecting for escape mutants during acute HIV-1
infection may possess a combination of activities that include both
killing and inhibitory activity. This possibility has also been suggested
in the SIV model where loss of HIV-infected CD4+ T cells was not
prevented by administration of antiretroviral therapy in CD8-
depleted animals, suggesting that CD8+ T cell functions other than
cytotoxic activity might contribute to early control of virus replication
and recovery of CD4 counts [49,50].
Neither the magnitude, the phenotype, nor the functionality of
CD8+ T cell responses at time of HRF showed any association
with the appearance of escape mutants. These lack of associations
could be related to several factors: 1) our inability to detect the true
peak of responses; 2) the fact that the maturation of responding
cells may be impaired by high levels of virus replication; and 3)
rapid appearance of escape mutants.
Our data indicate that high entropy at the population level is
significantly associated with the appearance of escape within the first six
months post-infection, extending observations made in previous studies
of escape in acute infection [51,52]. Epitopes that exhibited delayed
escape despite an early response were associated with low entropy at
the population level, hence higher fitness costs may be associated with
change in these epitopes. Our finding is in line with results from earlier
studies that have demonstrated the role of fitness costs of sequence
changes in/around CD8+ T cell epitopes in constraining escape from
epitope-specific responses [6,16,26]. Delayed escape was also associ-
ated with less vigorous CD8+ T cell responses as revealed by lower total
response magnitudes assessed by ICS.
Overall, our data show that fully multifunctional (5+) Gag-
specific CD8+ T cell responses are not detectable during the initial
weeks following HIV-1 infection in the response to the transmitted
virus. Moreover, the relative contribution of 3- and 4-multifunc-
tional subsets to the total response is small, although it increases
with time from initial infection. Importantly, the magnitude of
epitope-specific CD8+ T cell responses including the frequency of
epitope-specific MIP-1b -producing cells is associated with the
order of appearance of escape mutants. The order in which
different epitopes escaped CD8 responses is also associated with
the population diversity (entropy) of the epitopes. These findings
underscore the important role that the magnitude of the CD8+ T
cell responses plays in exerting pressure on replication of
transmitted/founder HIV-1 in the early stages of infection, and
illustrate the importance of considering both epitope entropy and
functional responses beyond the cytotoxic properties of epitope-
specific CD8+ T cells for vaccine design.
Methods
Subjects
The seven individuals enrolled in this study were identified as
acutely HIV-1-infected by the presence of detectable HIV-1 viral
RNA in their plasma, but either negative or discordant HIV-1
serology at the screening visit. Three infected patients (CH040,
CH058 and CH077) were enrolled in the CHAVI 001 study at the
Duke University Medical Center and Chapel Hill UNC-Hospital
(USA). Four additional patients (MM33, MM39, MM42 and
MM43) were recruited at the Mortimer Market Center (London,
UK). CD4 cell counts and viral loads were determined by local
accredited clinical laboratories. The Fiebig stage was determined
as previously reported [53]. All seven individuals remained
HAART naı¨ve for the duration of the study.
PBMC were isolated by standard density gradient centrifugation
from anti-coagulated blood samples, within 8 hours of collection.
PBMC were viably cryopreserved in fetal calf serum supplemented
with 10% DMSO and stored in vapor phase liquid nitrogen.
PBMC samples were also obtained from 16 HIV-1 seronegative
individuals as a control group.
Each participant enrolled in the study provided written
informed consent in conjunction with protocols approved by the
institutional review boards of Duke University Medical Center and
the Mortimer Market Center for Sexual Health and HIV research.
Sequence analysis of transmitted virus isolates
Sequences of the transmitted virus were derived from plasma
obtained at either the screening or enrollment visit. RNA
extraction, complementary DNA synthesis, and sequence analysis
were performed as previously described [26,54]. GeneBank
accession numbers for sequences are as follows: HM586186-
HM586209 correspond to 24 bulk sequences from MM33,
MM39, MM2, and MM43; HM153284-HM153412 correspond
to 129 SGA sequences from MM39 and MM43; and FJ495804-
FJ496071, FJ496086-FJ496144, and FJ919955-FJ919967 include
340 SGA sequences derived from CH40, CH58, and CH77.
Alternatively, longitudinal alignments from subjects CH40, CH58
and CH77 can be found at http://www.hiv.lanl.gov/content/
sequence/HIV/USER_ALIGNMENTS/Salazar.html as previ-
ously published [54].
Peptides
Eighteen amino acid peptides, overlapping by 10 amino acid
residues, were synthesized based on the autologous transmitted
HIV-1 sequences for each infected study subject as previously
described [6,26].
T cell epitope mapping
The viral peptides recognized by the primary HIV-specific T
cell response in each patient were identified by ex vivo interferon-
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gamma (IFN-c) ELISpot assay as previously reported [6,26].
Briefly, PBMC were thawed and, after overnight (CH040/058/
077–2 hr resting) resting, stimulated with peptide pools at a final
concentration of 2 mg/ml for 20–24 hr at 37uC in 5% CO2. For
each assay, six negative control wells (no antigen) and triplicate
wells of at least 1 positive control (PHA at 10 mg/ml; Sigma-
Aldrich) were included. Each epitope-specific response identified
from the screening was confirmed in a secondary assay, and, for
some responses, by testing the recognition of shorter peptides A
criteria of positivity of $50 Spot Forming Cells (SFCs)/106 cells
and .3x background was established.
Multi-parameter intracellular cytokine staining assay
Cryopreserved PBMC were thawed and rested overnight.
PBMC were stimulated with individual or pools of peptides
representing the sequence of the autologous transmitted HIV-1
isolate. For all subjects, a polyclonal stimulation with the
superantigen Staphylococcus aureus enterotoxin B (SEB) was also
used as positive control. Each antibody was titered to determine
the saturating concentration used for the final staining. The
stimulations were conducted in the presence of 1 mg/ml anti-
CD28 mAb (clone L293; BD), 1 mg/ml anti-CD49d mAb (clone
L25; BD), anti-CD107a Alexa Fluor 680 (clone H4A3; BD), 5 mg/
ml brefeldin A (Sigma-Aldrich) and 1 mg/ml of Golgi Stop (BD)
for 5.5 h at 37uC in 5% CO2. After washing, the cells were surface
stained with anti–CD4-Cy5.5-PE (clone M-T477; Biolegend),
anti–CD8-QD705 (clone RPA-T8; InVitroGen), anti–CD27-Cy5-
PE (clone M-T271, BD Bioscience), anti–CD57-QD565 (clone
NK-1, AbD; conjugated in M. Betts Lab), and anti–CD45RO-
PE–Texas Red (clone UCHL1, Beckman Coulter) for 20 min at
room temperature. Admixtures of anti–CD14–Cascade blue
(clone M5E2, Biolegend), anti–CD19–Cascade blue (clone HIB
19, Biolegend), and a vital dye (ViVid; InVitroGen) were also used
to exclude monocytes/macrophages, B cells, and non-viable cells
from the analysis.
PBMC were subsequently fixed and permeabilized with
Cytofix/Cytoperm and Perm/Wash buffer (Pharmingen, San
Diego, CA) for 20 minutes, washed twice, and stained with anti–
CD3-Cy7-APC (clone SK7, BD Bioscience), anti–IFN-c–FITC
(B27), anti–IL-2–APC (clone MQ1-17H12), anti–TNF-a–Cy7-PE
(clone MAb11), and anti–MIP-1b-PE (clone D21-1351; all
obtained from BD) for 1 h at 4uC. After washing and fixation,
samples were acquired on a custom made LSRII (BD Bioscience,
San Jose, CA) within the next 24 hours. A minimum of 300,000
total viable events was acquired for each test.
Gating strategy
Gates were set to include singlet events, live CD3+ cells,
lymphocytes, and CD4+ and CD8+ subsets (Figure 1). From the
total CD8+ population, the naive subset was identified as
CD45RO2CD27+. This subset was excluded from the subsequent
analysis, and only the memory population was included, indicated
by the red gate in Figure S1.I. Within the memory population,
the central memory CD45RO+CD27+ (CM; RO+27+), effector
CD45RO+CD57+ (E; RO+57+), and the terminal effector
CD45RO2CD57+ (TE; RO257+) populations were identified.
Antigen-specific populations were identified within the memory
population as single-function cells shown in the sequential single
cytokine/chemokine/degranulation gates. Thirty-two poly-func-
tional subsets were identified using a Boolean gating strategy that
included both the functions and memory phenotype of the cells.
Based on the initial 32 functional subsets, we calculated the
frequency of the total CD8+ memory response as well as of the
total frequency of families of subsets having the same numbers of
functional parameters as shown in Figure S1.II.
Data analysis
Data analysis was performed using FlowJo 8.8.4 software
(TreeStar), Pestle for background subtraction, and SPICE for
frequency analysis. Pestle and SPICE were kindly provided by Dr.
M. Roederer Vaccine Research Center, NIH, Bethesda, MD.
Based on the results obtained with the sixteen seronegative
subjects (Figure S2), responses were considered positive if the
percentage of antigen-specific cells was 2-fold above the
background and greater than 0.05% after background subtraction
for at least two of the functional parameters.
Assigning the rank order of timing of escape mutations
Sequence analysis of epitope-containing regions was performed
at multiple time points over the first 87 weeks of infection. For
some samples and epitopes, many single gene amplification (SGA)
sequences were obtained spanning the epitope, and for others,
particularly samples that were sequenced in the context of
previous studies [26], only a single direct population sequence
was available (see supporting information for a complete listing of
epitope sequences at each time point studied). Direct sequences
readily detect mixed bases at positions if they are present in
roughly 25% of the population. The times at which the first
evidence for selection of sequence changes in/around epitopes and
the last traces of the transmitted epitope were observed were
determined.
Evaluation of the entropy of each epitopic region
To test the hypothesis that the pace of early escape may
correlate with the capacity of the epitope to readily tolerate
mutations, reflected in diversity of the epitope at the population
level, we used Shannon entropy as a measure of epitope diversity.
Shannon entropy (
P
i
pilnpi where p is the probability of the i
th
form of the epitope), is an information theory measure of the
uncertainty in a variable [55]. The Shannon entropy can be used
to compare the variability in positions or regions in protein
alignments [56,57]. Here we extracted each epitope region studied
from the B subtype of Los Alamos database web alignments using
the database tool QuickAlign (www.hiv.lanl.gov), and used the
observed frequency of each epitope variant to estimate the
probability of a given variant and to calculate the entropy. The
database alignments that we used contained a single randomly
selected sequence per infected person, to be representative of the
circulating population, and included between 500–1000 sequenc-
es, depending on what was available for a given protein. Entropy is
thus reported as a measure of epitope variation at the population
level; the higher the value the more variable the epitope, both in
terms of the number of variant forms and the distribution of their
frequencies. If the defined epitope was 9 amino acids long, we used
the precise epitope fragment; if it was longer or not precisely
defined within the reactive peptide, we used the 9 amino acids
centered on the escape mutations observed in the subject, so each
epitope region studied was exactly 9 amino acids long and thus we
could compare relative entropy values between epitopes.
Statistical analysis
A statistical test for linear trend in mean values over the six time
points was computed to analyze each degree of polyfunctionality
for the Gag-specific responses. A linear mixed effects (LME) model
was fit to the Gag-specific longitudinal data to account for
correlations amongst the measurements over time.
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A generalized linear mixed model assuming a normal
distribution was used to analyze the contribution of T cell
responses and epitope entropy to predicting the rank order of
escape across all subjects using the statistical package R (http://
www.R-project.org). To determine if these variables were
correlated to the within-subject rank-order of escape, we
calculated the non-parametric Spearman’s r statistic comparing
either the ranks of the epitope entropy or the T cell response level
with the sequential timing of escape for each subject. Spearman’s r
was calculated for each the 5 subjects with multiple epitopes
studied, and the r’s were summed. We then randomized within-
subject data 100,000 times, and a recalculated the sum of the r’s
for each of the randomized data sets. This provided a Monte Carlo
framework to test against the null that within-subject ranks were
not correlated.
Supporting Information
Figure S1 Gating strategy. I. The initial gates were set to include
singlet events, live CD3,+ cells, lymphocytes, and CD4+ and CD8+
subsets. From the total CD8+ subset, we identified the
CD45RO2CD27+ total naive subset (Naive) and excluded this from
the subsequent analysis. Within the memory population, the central
memory (CM) CD45RO+CD27+, effector memory (EM)
CD45RO+CD27- and the terminal effector (TE) CD45RO2CD57+
populations were identified. Five antigen-specific populations were
subsequently identified within the memory populations. II. Boolean
gate combinations were also used to define cells that exhibited only
one of any of the five functions ("1+"), any two of five ("2+"), and so
forth, up to cells that exhibited all five functions simultaneously ("5+").
"Pies" represent the colour codes for each of the five functional
families that are used in the pie charts throughout the paper.
Found at: doi:10.1371/journal.ppat.1001273.s001 (0.83 MB TIF)
Figure S2 Background reactivity in HIV seronegative controls.
I. The dot-plots in the top row represent an example of the
frequency of CD107+, IFN-c+, IL-2+, MIP-1b+, and TNF-a+
CD8+ T cells identified according to the strategy illustrated in
Figure S1 in samples collected from HIV-seronegative donors in
the absence of antigen stimulation (unstimulated condition
representing the background). In the second row, we show an
example of the frequency of cells responding to stimulation with a
pool of peptides representing the Gag sequence. The average
frequencies (6 standard deviation) of CD107+, IFN-c+, IL-2+,
MIP-1b+, and TNF-a+ CD8+ T cell populations were 0.06
(60.04), 0.03 (60.04), 0.05 (60.07), 0.06 (60.04), 0.0460.03,
respectively, for the unstimulated condition. The analysis of the
responses to Gag peptide pool in the same subjects revealed
average frequencies (6 standard deviation) of 0.07 (60.06), 0.06
(60.07), 0.07 (60.08), 0.06 (60.06), 0.05 (60.03) for CD107+,
IFN-c+, IL-2+, MIP-1b+, and TNF-a+ CD8+ T cell populations,
respectively. II. Each figure represents the frequency of the
responding cells in each of the 16 HIV seronegative donors for
each functional measurement. The frequencies observed in each
donor for the unstimulated and Gag peptide pool stimulated
conditions are connected. In no instance was Gag-specific
reactivity for each functional parameter 2-fold higher than the
background and greater than 0.05 after background subtraction.
Found at: doi:10.1371/journal.ppat.1001273.s002 (0.51 MB
TIF)
Text S1 List of transmitted/founder and escape epitope
sequences utilized for the analyses.
Found at: doi:10.1371/journal.ppat.1001273.s003 (0.06 MB
DOC)
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